TherapeuticsMD Ownership | Who Owns TherapeuticsMD?


OverviewForecastRevenueFinancialsChart

TherapeuticsMD Ownership Summary


TherapeuticsMD is owned by 11.30% institutional investors, 1.71% insiders, and 87.00% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 10.34% of TXMD shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.16% of its assets in TherapeuticsMD shares.

TXMD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTherapeuticsMD11.30%1.71%87.00%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.69%10.91%62.39%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rubric capital management lp1.19M10.34%$1.03M
Clearline capital lp635.22K5.51%$546.29K
Tejara capital394.66K3.42%$339.41K
Vanguard group387.58K3.36%$333.32K
Adar1 capital management270.16K2.34%$232.34K
Morgan stanley131.60K1.14%$211.88K
Blackrock125.15K1.09%$201.50K
Blackrock funding, inc. /de116.13K1.01%$99.87K
Geode capital management108.33K0.94%$93.20K
Bridgeway capital management34.00K0.29%$29.24K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tejara capital394.66K0.22%$339.41K
Clearline capital lp635.22K0.07%$546.29K
Adar1 capital management270.16K0.05%$232.34K
Rubric capital management lp1.19M0.01%$1.03M
Bridgeway capital management34.00K0.00%$29.24K
J. goldman & co lp13.56K0.00%$11.66K
Tower research capital llc (trc)4.78K0.00%$4.11K
Guardian wealth management2.00-$2.00
Blackrock125.15K-$201.50K
Geode capital management108.33K-$93.20K

Top Buyers

HolderShares% AssetsChange
Renaissance10.89K-10.89K
Tower research capital llc (trc)4.78K0.00%2.51K
Group one trading1.14K-1.14K
Bnp paribas arbitrage, snc224.00-224.00
Bank of america corp /de/487.00-87.00

Top Sellers

HolderShares% AssetsChange
Clear harbor asset management---25.81K
Prosperity consulting group---24.50K
Two sigma securities---14.36K
Gabelli funds---12.00K
Blackrock125.15K--10.63K

New Positions

HolderShares% AssetsChangeValue
Renaissance10.89K-10.89K$9.37K
Group one trading1.14K-1.14K$976.00K
Bnp paribas arbitrage, snc224.00-224.00$193.00
Newedge advisors3.00-3.00$3.00
Northwestern mutual wealth management2.00-2.00$2.00

Sold Out

HolderChange
Sterling capital management-1.00
Aspire private capital-1.00
Qube research-2.00
Old point trust & financial services n a-50.00
Principal securities-126.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202424-31.43%1,302,899-61.44%111.32%8-3-25.00%
Sep 30, 202434-8.11%3,378,926-0.87%293.35%8-4-60.00%
Jun 30, 202437-13.95%3,408,5500.93%293.45%8-38.46%1011.11%
Mar 31, 20244316.22%3,377,1773.85%293.17%1385.71%9-30.77%
Dec 31, 202337-3,251,8479.41%303.59%7-36.36%13116.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF249.66K2.16%-
Vanguard Total Stock Mkt Idx Inv249.66K2.16%-
Vanguard Institutional Extnd Mkt Idx Tr122.23K1.06%-
Fidelity Extended Market Index62.33K0.54%-397.00
Bridgeway Ultra-Small Company Market34.00K0.29%-
BlackRock Extended Equity Market K16.29K0.14%-7.00
Extended Equity Market Fund K16.11K0.14%49.00
Fidelity Series Total Market Index15.32K0.13%-
Fidelity Total Market Index14.84K0.13%-
NT Ext Equity Mkt Idx Fd - NL8.76K0.08%-

Recent Insider Transactions


DateNameRoleActivityValue
Apr 14, 2025Thompson Tommy G-Buy$325.59
Apr 14, 2025Walker Marlan D Chief Executive OfficerBuy$489.27
Apr 09, 2025Walker Marlan D Chief Executive OfficerBuy$993.66
Apr 10, 2025Walker Marlan D Chief Executive OfficerBuy$1.00K
Aug 22, 2024Collins Cooper C.-Buy$7.10K

Insider Transactions Trends


DateBuySell
2025 Q22-
2025 Q1--
2024 Q32-
2023 Q4-2
2023 Q3--

TXMD Ownership FAQ


Who Owns TherapeuticsMD?

TherapeuticsMD shareholders are primarily institutional investors at 11.30%, followed by 1.71% insiders and 86.99% retail investors. The average institutional ownership in TherapeuticsMD's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.69%, which TherapeuticsMD falls below.

Who owns the most shares of TherapeuticsMD?

TherapeuticsMD’s largest shareholders are Rubric capital management lp (1.19M shares, 10.34%), Clearline capital lp (635.22K shares, 5.51%), and Tejara capital (394.66K shares, 3.42%). Together, they hold 19.27% of TherapeuticsMD’s total shares outstanding.

Does Blackrock own TherapeuticsMD?

Yes, BlackRock owns 1.09% of TherapeuticsMD, totaling 125.15K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 201.5K$. In the last quarter, BlackRock decreased its holdings by -10.627K shares, a -7.83% change.

Who is TherapeuticsMD’s biggest shareholder by percentage of total assets invested?

Tejara capital is TherapeuticsMD’s biggest shareholder by percentage of total assets invested, with 0.22% of its assets in 394.66K TherapeuticsMD shares, valued at 339.41K$.

Who is the top mutual fund holder of TherapeuticsMD shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of TherapeuticsMD shares, with 2.16% of its total shares outstanding invested in 249.66K TherapeuticsMD shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools